134 related articles for article (PubMed ID: 1694132)
21. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
22. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
[TBL] [Abstract][Full Text] [Related]
23. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
24. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
25. Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation.
Namciu S; Lieberman MA; Stavnezer E
Oncogene; 1994 May; 9(5):1407-16. PubMed ID: 8152801
[TBL] [Abstract][Full Text] [Related]
26. Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
Lilly M; Tompkins C; Brown C; Pettit G; Kraft A
Cancer Res; 1990 Sep; 50(17):5520-5. PubMed ID: 2386956
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells.
Lozano F; Alberola-Ila J; Places L; Gallart T; Vives J
Immunology; 1990 Aug; 70(4):434-9. PubMed ID: 1697562
[TBL] [Abstract][Full Text] [Related]
28. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.
Phelan SA; Lindberg C; Call KM
Cell Growth Differ; 1994 Jun; 5(6):677-86. PubMed ID: 8086342
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells.
Gong Y; Alkhalaf B; Murphy LJ; Murphy LC
Cell Growth Differ; 1992 Nov; 3(11):847-53. PubMed ID: 1467312
[TBL] [Abstract][Full Text] [Related]
30. Effects of bryostatins and retinoic acid on phorbol ester- and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells.
Jetten AM; George MA; Pettit GR; Rearick JI
Cancer Res; 1989 Jul; 49(14):3990-5. PubMed ID: 2567623
[TBL] [Abstract][Full Text] [Related]
31. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
[TBL] [Abstract][Full Text] [Related]
32. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
[TBL] [Abstract][Full Text] [Related]
33. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
[TBL] [Abstract][Full Text] [Related]
34. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
[TBL] [Abstract][Full Text] [Related]
36. Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.
Ning ZQ; Hirose T; Deed R; Newton J; Murphy JJ; Norton JD
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):59-65. PubMed ID: 8870649
[TBL] [Abstract][Full Text] [Related]
37. Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
Gartenhaus R; Hoffman M; Fuchs A; Billet H; Wang P; Gentile P; Rai K
Leuk Lymphoma; 1996 Jun; 22(1-2):97-101, follow.186, color plate IX. PubMed ID: 8724534
[TBL] [Abstract][Full Text] [Related]
38. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of immunoglobulin expression in a chronic lymphocytic leukemia cell line.
Mårtensson IL; Nilsson K; Leanderson T
Eur J Immunol; 1989 Sep; 19(9):1625-9. PubMed ID: 2507325
[TBL] [Abstract][Full Text] [Related]
40. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
Vilpo J; Hulkkonen J; Hurme M; Vilpo L
Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
